AMRI Announces First Quarter 2015 Results

Go back to AMRI Announces First Quarter 2015 Results

Albany Molecular Research (AMRI) Tops Q1 EPS by 5c

May 5, 2015 7:32 AM EDT

Albany Molecular Research (NASDAQ: AMRI) reported Q1 EPS of $0.20, $0.05 better than the analyst estimate of $0.15. Revenue for the quarter came in at $75.1 million versus the consensus estimate of $81.5 million.

For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.

... More